Market Indices
Latest News
 |
| ||
| ||
| ||
|
Price Targets
from Canaccord Genuity issued a price target of $8.00 for ATAI on 2026-07-16 18:59:06.The adjusted price target was set to $8.00.At the time of the announcement, ATAI...
July 16, 2026 ATAI 32.56%
from Northland Securities issued a price target of $3.75 for GEVO on 2026-07-16 13:06:14.The adjusted price target was set to $3.75.At the time of the announcement, GEVO...
July 16, 2026 GEVO 0.94%
David Feaster from Raymond James issued a price target of $66.00 for PLBC on 2026-07-16 12:49:52.The adjusted price target was set to $66.00.At the time of the announcement,
July 16, 2026 PLBC 2.42%
from Truist Financial issued a price target of $178.00 for BNY on 2026-07-16 12:02:54.The adjusted price target was set to $178.00.At the time of the announcement, BNY...
July 16, 2026 BNY -1.02%
from Goldman Sachs issued a price target of $177.00 for BNY on 2026-07-16 11:51:47.The adjusted price target was set to $177.00.At the time of the announcement, BNY...
July 16, 2026 BNY -1.02%
Market Movers
| Top Gainers (%) | |||||||||||||||||||
| ATPC Agape ATP Corporation | 4.17
65.48% | ||||||||||||||||||
| ATAI Atai Beckley Inc. | 7.11
32.56% | ||||||||||||||||||
| BZFDW BuzzFeed, Inc. | 0.02
13.29% | ||||||||||||||||||
| HRTX Heron Therapeutics, Inc. | 0.50
12.78% | ||||||||||||||||||
| CRDL Cardiol Therapeutics Inc. | 1.25
12.16% | ||||||||||||||||||
| OPRT Oportun Financial Corpora | 6.33
11.64% | ||||||||||||||||||
| AHT-PH Ashford Hospitality Trust | 5.40
10.88% | ||||||||||||||||||
| JSPR Jasper Therapeutics, Inc. | 0.77
10.68% | ||||||||||||||||||
Annual/Quarterly Reports Summary
In a landscape marked by rapid technological advancements, the company saw a revenue increase of $1.4 million for the three months ending September 30, 2024, fueled by new licenses and...
November 6, 2024 AIP -6.23%
In a landscape of fluctuating revenues, the company celebrated a 25% revenue increase in Q3 2024, yet faced a 14% decline over nine months due to production challenges. Operating expenses...
November 6, 2024 EOSEW -34.96%
In a landscape marked by financial challenges, the company faced fluctuating revenues, with a notable 25% increase in Q3 2024 overshadowed by a 14% decline over nine months. Operating losses...
November 6, 2024 EOSE -9.27%
In a tale of growth and ambition, the company witnessed its revenue soar from $6.0 million to $13.9 million, fueled by partnerships with Acadia Pharmaceuticals. However, operating expenses, particularly in...
November 5, 2024 STOK -3.88%
In a transformative period, the company experienced a remarkable surge in revenue, driven by newly acquired oil and gas assets. Operating expenses showed notable trends, with a decrease in occupancy...
November 5, 2024 BSVN -1.82%